- 1Department of Geriatric Medicine, Hospital Universitario de Navarra (HUN), Pamplona, Spain
- 2Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdisNa), Universidad Pública de Navarra (UPNA), Pamplona, Spain
- 3Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdisNa), Universidad Pública de Navarra (UPNA), Pamplona, Spain
- 4Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
Delirium is an important cause of morbidity and mortality in older adults admitted to hospital. Multicomponent interventions targeting delirium risk factors, including physical exercise and mobilization, have been shown to reduce delirium incidence by 30–40% in acute care settings. However, little is known about its role in the evolution of delirium, once established. This study is a randomized clinical trial conducted in the Acute Geriatric Unit of Hospital Universitario de Navarra (Pamplona, Spain). Hospitalized patients with delirium who meet the inclusion criteria will be randomly assigned to the intervention or the control group. The intervention will consist of a multicomponent exercise training program, which will be composed of supervised progressive resistance and strength exercise over 3 consecutive days. Functional Near-Infrared Spectroscopy (NIRS) will be used for assessing cerebral and muscle tissue blood flow. The objective is to assess the effectiveness of this intervention in modifying the following primary outcomes: duration and severity of delirium and functional status. This study will contribute to determine the effectiveness of physical exercise in the management of delirium. It will be the first study to evaluate the impact of a multicomponent intervention based on physical exercise in the evolution of delirium.
Clinical trial registration: ClinicalTrials.gov. identifier: NCT05442892 (date of registration June 26, 2022).
Introduction
Delirium is an acute onset and fluctuating syndrome that is characterized by disturbances in level of awareness, attention, and other cognitive functions (Helfand et al., 2021). It is highly prevalent among older adults across healthcare settings (8–17% reported in emergency departments, 20–29% in geriatric acute care, 13–50% in surgical patients, and 19–82% in intensive care units; Inouye et al., 2014). Furthermore, delirium is particularly important in older patients not only for its high incidence and prevalence but also for the great impact of its consequences including longer hospital stay, increased risk of institutionalization at discharge, higher cognitive and functional impairment, higher mortality, and greater healthcare costs (Jackson et al., 2017). In addition, geriatric inpatients often experience accelerated functional decline during hospitalization associated with long bed-rest episodes. Some studies have shown that more than 83% of these patients are bedridden and only 4% are permitted to stand or walk, which increases the risk of delirium and hinders its resolution once it is established (Covinsky et al., 2003; Brummel et al., 2014; Zisberg et al., 2015; Martínez-Velilla et al., 2016). Multicomponent interventions such as the Hospital Elder Life Program (HELP) have been shown to reduce delirium incidence in the acute care setting by 43%, by acting on modifiable risk factors such as dehydration, pain, sensory impairment, malnutrition, and immobility, compared to usual care (Hshieh et al., 2018; Wang et al., 2020; Burton et al., 2021).
However, there is little evidence on treatments for delirium. According to current clinical guidelines, the non-pharmacological approach focused on correcting the underlying causes should always be the first option, reserving pharmacological treatment for cases of extreme agitation [Davis et al., 2019; National Institute for Health and Care Excellence (NICE), 2022]. The scarce evidence is due to the fact that the pathophysiology of delirium remains unclear. Several mechanisms have been proposed to explain the development of delirium involving certain processes such as neuroinflammation, neuronal damage, neurotransmitter disturbance, and acute cerebral failure caused by hypoxia-ischemia. In the hypoxia-ischemia theory, there is a vascular dysfunction that produces endothelial injury and blood–brain barrier (BBB) damage, causing low oxygen delivery to the brain parenchyma and contributing to a metabolic insufficiency that allows delirium development (Wilson et al., 2020).
Physical exercise has been shown to improve cerebral blood flow, increasing neurogenesis and neuroplasticity through the release of neurotransmitters and neurotrophic factors such as insulin-like growth factor-1 (IGF-1) and Brain-Derived Neurotrophic Factor (BDNF; Ben-Zeev, 2022), providing synaptic transmission and improving cognitive function. Physical exercise also decreases the accumulation of amyloid plaques and tau protein which has been shown to improve cognitive functions such as attention, memory, executive tasks, and information processing speed (Erickson et al., 2019; Bliss et al., 2021; Cruz et al., 2022; Rai and Demontis, 2022; Silva et al., 2022). In fact, an individualized, multicomponent exercise training program may be an effective therapy for improving cognitive function in very old patients during acute hospitalization (de Asteasu et al., 2019, 2022), cognitive impairment (Venegas-Sanabria et al., 2022), and depression (Li et al., 2022). Therefore, we hypothesized that strategies that help improve oxygen supply to the brain, such as physical exercise, could be useful in treating delirium.
Although there are several techniques to monitor brain activity and cerebral blood flow (e.g., brain magnetic resonance, positron emission tomography, and electroencephalogram), Near-Infrared Spectroscopy (NIRS) could potentially be effective.
NIRS is a non-invasive physiological monitoring method that measures light absorbance to calculate oxy-hemoglobin (oxy-HB) and deoxy-hemoglobin (deoxy-HB), which provide an indirect measure of tissue oxygenation, often in the frontal cortex of the brain and muscle.
Some of the advantages that NIRS can offer are that is a non-invasive technology, which provides real-time continuous measurement of regional cerebral blood oxygenation and indirect blood flow indicating perfusion adequacy. Being a portable device, it can be moved to the place where the patient is, which facilitates its use. In addition, NIRS does not emit ionizing radiation and is less expensive than brain neuroimaging tests such as magnetic resonance imaging, providing added advantages such as the analysis of functional brain parameters while the patient performs different physical or cognitive tasks (Sakudo, 2016; Nguyen et al., 2019; Milej et al., 2020; Hogue et al., 2021).
Even though NIRS is used in different areas of Medicine, it has reached its greatest interest in Intensive Care and Anesthesiology for monitoring brain perfusion to avoid hypoxemia, which is associated with cognitive dysfunction and delirium (Schoen et al., 2011; Hori et al., 2014). Some studies have recently been published using NIRS as a predictive biomarker of postoperative delirium with promising results, where it has been observed that patients with low levels of cerebral oxygen saturation prior to surgery and during surgical intervention, had a higher incidence of postoperative delirium (Wood et al., 2017; Khan et al., 2021; Semrau et al., 2021; Susano et al., 2021). On the other hand, NIRS has been used to monitor hemodynamic response in the prefrontal cortex region and in lower-limb muscle tissue doing physical exercise and functional tasks in acutely hospitalized older patients (de Asteasu et al., 2021).
In spite of the growing number of studies published on the application of NIRS in delirium over the last few years, there are currently significant limitations so this evidence should be interpreted with caution (Chen et al., 2020). These studies often include a low sample size, are usually carried out in the field of surgery or the Intensive Care Unit (ICU), are heterogeneous in their composition, and have a high risk of bias. In addition, most of them do not consider the peculiarities of the older population, which is where delirium is most frequent. In most studies, essential information about older adults is not systematically collected, including geriatric syndromes (frailty, falls, and malnutrition), predisposing factors (comorbidity, functional, and cognitive status), and precipitating factors of delirium (pain, polypharmacy, use of urinary catheters).
The objective of this clinical trial is to evaluate the effect of a multicomponent exercise program on the development of delirium assessing cerebral and muscle perfusion using NIRS in hospitalized older adults. This study may help to understand the mechanisms underlying delirium, which are not yet totally clear in the literature, considering tissue oxygenation hypothesis.
Materials and methods
Study design
This study is a randomized clinical trial conducted in the 40-bedded Acute Geriatric Unit (AGU) of Hospital Universitario de Navarra (Pamplona, Spain). Hospitalized patients who meet the inclusion criteria will be randomly assigned to the intervention or control group. The study flow diagram is shown in Figure 1. After obtention of written informed consent, patients will be randomly assigned to either the intervention or control group. The data for both the intervention group and the control group will be obtained at five different times: the initial visit during the acute hospitalization, at discharge and at 1, 3, and 12 months after discharge through phone call and clinical history. The times of measurement of the different outcomes is shown in Table 1.
Peripheral blood (PB) samples will be obtained from all patients at baseline and at discharge. EDTA blood collection tubes (Vacuette®, Greiner Bio-One) will be used. All PB samples will be centrifuged in a fixed-angle rotor at 3,300 rpm for 10 min at room temperature. After centrifugation, the serum in the upper layer will be carefully extracted from the plasma in the bottom layer, divided into 100 μL, and immediately stored at −80°C. Plasma and buffy coat will be also extracted and stored in polypropylene plastic tubes at −80°C.
We aim to examine the brain function during delirium and the effects of an intra-hospital exercise program on the prefrontal cortex region and on muscle function with the use of NIRS. Regional oxygen saturation (rSO2) in the forehead and vastus lateralis muscle will be recorded using NIRS using the NIRO-200NX C10448 monitor (Hamamatsu, Japan) by placing one optode on the patient’s forehead above the eyebrow and the other optode on the vastus lateralis muscle (Koyama et al., 2013; Udina et al., 2020). The measurements will be made with the patients resting in the sitting position during 60 s, doing trail making test part A and the assessment of 10 reps x 50% 1RM at the beginning of the study and the 4th day of the study, in both intervention and control groups. There are some factors which may alter NIRS parameters because they influence cerebral perfusion such as drugs, blood pressure, hemoglobin, or oxygen saturation. Although we will evaluate all of them, this is an important limitation of the study.
Delirium will be assessed using the European Spanish version of the 4AT (Delgado-Parada et al., 2022) daily during hospitalization until discharge. This tool has been validated for the Spanish population and is a reliable instrument for delirium detection in older patients. The 4AT scale is designed to be used as a delirium detection tool in general clinical settings. The 4AT has four parameters: Alertness, Abbreviated mental test-4 (AMT4), Attention (months backward test), and Acute change or fluctuating course. The score range is 0–12, with scores of 4 or more suggesting possible delirium. Scores of 1–3 suggest possible cognitive impairment (Jeong et al., 2020; Tieges et al., 2021). Delirium severity will be evaluated daily with the Memorial Delirium Assessment Scale (MDAS) which is also validated in Spain (Noguera et al., 2014; Barahona et al., 2018). MDAS was designed to diagnose delirium as well as classify delirium severity. The instrument reflects delirium diagnostic criteria from DSM. It has 10 severity items rated 0 to 3 points for a maximum total score of 30 points, with higher scores representing more severe delirium (Jones et al. 2019).
The protocol employs relevant standard protocol items for clinical trials according to the SPIRIT 2013 statement (Chan et al., 2013) and follows the CONSORT statement (Moher et al., 2001). The trial is registered at ClinicalTrials.gov, identifier NCT05442892. This study was approved by the Navarra Clinical Research Ethics Committee (PI_2021/94).
Study participants and eligibility criteria
Medical inpatients admitted to the AGU of Hospital Universitario de Navarra (Pamplona, Spain) between February 2022 and February 2023.
The inclusion criteria are:
– Age: 75 years or older with delirium during hospitalization.
– Able to ambulate with or without personal/technical assistance.
– Barthel Index ≥45 points 2 weeks before admission.
– Informed consent by patients (if possible), relatives, or legal representatives.
The exclusion criteria are:
– Duration of hospitalization <5 days.
– Severe dementia (GDS 6–7).
– Terminal illness (life expectancy less than 3 months).
– Any factor precluding performance of physical exercise. These factors include:
– Acute myocardial infarction in the past 3 months or unstable angina
– Severe heart valve insufficiency.
– Arrhythmia or uncontrolled arterial hypertension.
– Pulmonary embolism in the past 3 months.
– Hemodynamic instability.
– Pathology that could interfere with NIRS registration:
– Facial dermal pathology (front).
– Acute intracranial pathology (hemorrhages, cerebral infarcts).
Randomization and blinding
The study participants will be randomized1 into intervention or control group. Assessment staff will be blinded to the participant randomization assignment, as well as to the main study design and to what changes we expect to occur in the study outcomes in each group. It will not be possible to conceal the group assignment from the staff involved in the training of the intervention group. Patients and their families will be informed of the random inclusion in one group but will not be informed as to which group they belong.
Sample size
Assuming a standard deviation in MDAS scale of 6 points, for a power of 80% and a significance level of 0.05, 24 patients per group (a total of 48) will be necessary to detect a mean difference of 5 points between groups. Assuming 20% losses, 30 patients per group will be necessary.
Statistics
The baseline value of the included variables will be described for the whole sample and separated by group using frequencies and percentages for the categorical ones and via mean and standard deviation or median and interquartile range for continuous ones. In order to assess the extent of the therapeutic effect, we will compute for every patient the difference between final and initial levels of the continuous outcome variables. Then, these differences will be compared by intervention group, using t-tests or Mann–Whitney U tests. For the mortality outcome, the percentage mortality of both groups will be compared using the Chi-square test. In case of observing relevant differences at baseline, these comparisons will be adjusted by the baseline value, using linear models or generalized linear models. The level of statistical significance will be 0.05. Data will be analyzed with SPSS package 28.0.
Detailed description
Usual care group (control)
Participants randomly assigned to the usual care group will receive normal hospital care, which includes physical rehabilitation when needed.
Intervention group (training)
The intervention will consist of a multicomponent exercise training program adapted from Vivifrail to prevent muscle weakness and falls (Izquierdo et al., 2017; Casas-Herrero et al., 2022) and the training protocol was detailed in previous literature (Martínez-Velilla et al., 2015, 2016, 2019, 2022). It will be composed of supervised progressive resistance exercise training, balance training, and walking for 3 consecutive days. During the training period, patients will be trained in 30 min sessions once a day (morning). The supervised multicomponent exercise training program will be comprised of upper and lower body strengthening exercises, tailored to the individual’s functional capacity, using weight machines and aiming for 2–3 sets of 8–10 repetitions at an intensity of 50–70% of 1RM (Matrix, Johnson Health Tech, Ibérica, S.L. Torrejón de Ardoz, Madrid, Spain). A “1RM” signifies the maximum resistance a person can move in one repetition of an exercise. The resistance exercises focused on the major upper and lower limb muscles. On the second and third training days, patients do 2 sets of 10 chair squats. Each resistance training session will include 2 exercises for the leg extensor muscles (bilateral leg press and bilateral knee extension machines) and 1 exercise for upper limbs (seated bench press machine). During the progressive resistance training, instruction will be provided to the participants to perform the exercises at a high velocity of motion. However, care will be taken to ensure that exercises are executed with correct form. In the first assessment, the patients will warm up with specific movements for the exercise test. Each subject’s maximal load will be determined in no more than five attempts. During all neuromuscular performance tests, a strong verbal encouragement will be given to each subject to motivate them to perform each test action as optimally and rapidly as possible. Three experienced physical trainers (FZF, IOM, and ADM) will carefully monitor and supervise all training sessions and provide instruction and encouragement. Adherence to the exercise intervention program will be documented in a daily register of sessions and adverse events including muscle pain, fatigue, falls and general aches will be recorded by the training staff. Participants and their family members will be carefully familiarized with the training procedures in advance. The intervention exercises are detailed in Table 2 and the training protocol is shown in Figure 2.
Outcome measures
Primary outcome
• Duration and severity of delirium during the hospitalization between both intervention and control group and the change in functional status: 4AT and MDAS scale.
• Functional capacity of patients will be evaluated by the Short Physical Performance Battery (SPPB), which evaluates, balance, gait ability, and leg strength using a single tool. The total score will range from 0 (worst) to 12 points (best). The SPPB test has been shown to be a valid instrument for screening frailty and predicting disability, institutionalization, and mortality (Guralnik et al., 1994). Daily functional status will be also assessed with the Hierarchical Assessment of Balance and Mobility (HABAM) with is an instrument that provides a clinical assessment of in-bed mobility, transfers, and ambulation (Gual et al., 2019; Richardson et al., 2021). The lowest number, a value of 0, is equal to the lowest or no performance. Changes in these abilities can then be compared with patient progress.
• Regional oxygen saturation (rSO2) will be measured using NIRS (Luo et al., 2018; Pfeifer et al., 2018).
Secondary outcome
• Cognitive status: Global Deterioration Scale (GDS) which describes 7 clinically distinguishable global stages, from normality to severe dementia of the Alzheimer type (Reisberg et al., 1982; Auer and Reisberg, 1997) and the Informant Questionnaire on Cognitive Decline in the Elderly short form (IQCODE) which is a 16-question form, each question is scored from 1 (much improved) to 5 (much worse) and a cutoff point (average score) of 3.31/3.38 achieves a balance of sensitivity and specificity of cognitive impairment (Blandfort et al., 2020; Harrison et al., 2021).
• Functional status: Barthel Index of independence during activities of daily living (ADLs). This index ranges from 0 worst to 100 best (Barthel, 1965).
• Mortality.
• Quality of life: EuroQol Scale-5D. This instrument measures 5 dimensions of health status: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression (Herdman et al., 2001; García-Gordillo et al., 2015).
• Use of health sources: New admissions to the hospital, admission to nursing homes, visits to the general practitioner, and to the emergency department.
• Falls.
Discussion
Given that the pathophysiology of delirium remains unclear and its pharmacological treatment once established has not been shown to be effective in addition to having serious side effects (extrapyramidal symptoms, sedation, arrhythmias…) physical exercise, due to its anti-inflammatory component and improvement of cerebral perfusion, can open as a new therapeutic option to explore. Other important aspect of our trial is the inclusion of older patients with mild cognitive decline and dementia. So far, most of trials in aged frail participants with these conditions are routinely excluded. The inclusion of participants with cognitive impairment in addition to frailty makes the trial novel with notable external validity compared with other previous trials in assessing the effect of individualized exercise programs on functional capacity, activities of daily living, and cognitive function. This study will both advance delirium-related knowledge and improve health outcomes through a program based on physical exercise. Moreover, this project will try to find new biomarkers of delirium that could be extrapolated to the usual clinical practice and help in its monitoring. Due to the high prevalence of delirium in this population and its serious consequences on morbidity and mortality, this intervention opens the possibility of a new therapeutic approach that can mitigate its impact. If our hypothesis is correct and shows that a multicomponent, individualized, and progressive exercise program in hospitalized older adults with delirium improves cognitive and functional status, a possible new targeted and therapeutic tool during hospitalization could be developed to implement delirium management.
Trial status
The trial commenced recruitment on 7 February 2022 and is currently open for recruitment. Recruitment will cease when 60 participants have been randomized. It is anticipated this target will be reached by February 2023.
Ethics statement
This study follows the principles of the Declaration of Helsinki (World Medical Association) and was approved by the Navarra Clinical Research Ethics Committee on September 15, 2021 (PI_2021/94). The patients/participants provided their written informed consent to participate in this study.
Author contributions
L-LV, FabiZ-F, AC-M, and IO-M developed the protocol in consultation with FabrZ-F, MS, MI, and NM-V. LL-V, FabiZ-F, AC-M, and IO-M were involved in the recruitment and evaluation of the patients. All authors contributed to the article and approved the submitted version.
Funding
NM-V received funding from “la Caixa” Foundation (ID 100010434), under agreement LCF/PR/PR15/51100006.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1013631/full#supplementary-material
Footnotes
References
Auer, S., and Reisberg, B. (1997). The GDS/FAST staging system. Int. Psychogeriatr. 9, 167–171. doi: 10.1017/S1041610297004869
Barahona, E., Pinhao, R., Galindo, V., and Noguera, A. (2018). The diagnostic sensitivity of the memorial delirium assessment scale—Spanish version. J. Pain Symptom Manag. 55, 968–972. doi: 10.1016/j.jpainsymman.2017.11.013
Blandfort, S., Gregersen, M., Rahbek, K., Juul, S., and Damsgaard, E. M. (2020). The short IQCODE as a predictor for delirium in hospitalized geriatric patients. Aging Clin. Exp. Res. 32, 1969–1976. doi: 10.1007/s40520-019-01412-2
Bliss, E. S., Wong, R. H. X., Howe, P. R. C., and Mills, D. E. (2021). Benefits of exercise training on cerebrovascular and cognitive function in ageing. J. Cereb. Blood Flow Metab. 41, 447–470. doi: 10.1177/0271678X20957807
Brummel, N. E., Jackson, J. C., Pandharipande, P. P., Thompson, J. L., Shintani, A. K., Dittus, R. S., et al. (2014). Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit. Care Med. 42, 369–377. doi: 10.1097/CCM.0b013e3182a645bd
Burton, J. K., Craig, L. E., Yong, S. Q., Siddiqi, N., Teale, E. A., Woodhouse, R., et al. (2021). Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst. Rev. 7:CD013307. doi: 10.1002/14651858.CD013307.pub2
Casas-Herrero, Á., Mikel, L., de Asteasu, S., Antón-Rodrigo, I., Sánchez-Sánchez, J. L., Montero-Odasso, M., et al. (2022). Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial. J. Cachexia. Sarcopenia Muscle 13, 884–893. doi: 10.1002/jcsm.12925
Chan, A. W., Tetzlaff, J. M., Gøtzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., et al. (2013). SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346, 1–42. doi: 10.1136/bmj.e7586
Chen, W. L., Wagner, J., Heugel, N., Jeffrey Sugar, Y., Lee, W., Conant, L., et al. (2020). Functional near-infrared spectroscopy and its clinical application in the field of neuroscience: advances and future directions. Front. Neurosci. 14, 1–15. doi: 10.3389/fnins.2020.00724
Covinsky, K. E., Palmer, R. M., Fortinsky, R. H., Counsell, S. R., Stewart, A. L., Kresevic, D., et al. (2003). Loss of Independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J. Am. Geriatr. Soc. 51, 451–458. doi: 10.1046/j.1532-5415.2003.51152.x
Cruz, P., Del, B., Ahmadi, M., Naismith, S. L., and Stamatakis, E. (2022). Association of Daily Step Count and Intensity with incident dementia in 78430 adults living in the UK. JAMA Neurol. 79, 1059–1063. doi: 10.1001/jamaneurol.2022.2672
Davis, D., Searle, S. D., and Tsui, A. (2019). The Scottish intercollegiate guidelines network: risk reduction and Management of Delirium. Age Ageing 48, 485–488. doi: 10.1093/ageing/afz036
de Asteasu, S., Mikel, L., Cuevas-Lara, C., García-Hermoso, A., Ramírez-Vélez, R., Martínez-Velilla, N., et al. (2022). Effects of physical exercise on the incidence of delirium and cognitive function in acutely hospitalized older adults: a systematic review with meta-analysis. J. Alzheimers Dis. 87, 503–517. doi: 10.3233/JAD-220103
de Asteasu, S., Mikel, L., Martínez-Velilla, N., Zambom-Ferraresi, F., Casas-Herrero, Á., Cadore, E. L., et al. (2019). Assessing the impact of physical exercise on cognitive function in older medical patients during acute hospitalization: secondary analysis of a randomized trial. PLoS Med. 16, e1002852–e1002814. doi: 10.1371/journal.pmed.1002852
de Asteasu, S., Mikel, L., Martínez-Velilla, N., Zambom-Ferraresi, F., Ramírez-Vélez, R., García-Hermoso, A., et al. (2021). Exercise effects on brain and muscle function in acutely hospitalized older patients assessed by functional near-infrared spectroscopy. J. Am. Med. Dir. Assoc. 22, 875–876. doi: 10.1016/j.jamda.2020.12.027
Delgado-Parada, E., Morillo-Cuadrado, D., Saiz-Ruiz, J., Cebollada-Gracia, A., Ayuso-Mateos, J. L., and Cruz-Jentoft, A. J. (2022). Diagnostic accuracy of the Spanish version of the 4AT scale (4AT-ES) for delirium screening in older inpatients. Eur. J. Psychiatry 36, 182–190. doi: 10.1016/j.ejpsy.2022.01.003
Erickson, K. I., Hillman, C., Stillman, C. M., Ballard, R. M., Bloodgood, B., Conroy, D. E., et al. (2019). Physical activity, cognition, and brain outcomes: a review of the 2018 physical activity guidelines. Med. Sci. Sports Exerc. 51, 1242–1251. doi: 10.1249/MSS.0000000000001936
García-Gordillo, M. Á., Del Pozo-Cruz, B., Adsuar, J. C., Cordero-Ferrera, J. M., Abellán-Perpiñán, J. M., and Sánchez-Martínez, F. I. (2015). Validación y Comparación de Los Instrumentos EQ-5D-3L y SF-6D En Una Muestra de Población Española Con Enfermedad de Parkinson. Nutricion Hospitalaria 32, 2808–2821. doi: 10.3305/nh.2015.32.6.9765
Gual, N., Richardson, S. J., Davis, D. H. J., Bellelli, G., Hasemann, W., Meagher, D., et al. (2019). Impairments in balance and mobility identify delirium in patients with comorbid dementia. Int. Psychogeriatr. 31, 749–753. doi: 10.1017/S1041610218001345
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., et al. (1994). A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission energetic cost of walking in older adults view project IOM committee on cognitive Agi. J. Gerontol. 49, M85–M94. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/8126356. doi: 10.1093/geronj/49.2.M85
Harrison, J. K., Stott, D. J., McShane, R., Noel-Storr, A. H., Swann-Price, R. S., and Quinn, T. J. (2021). Informant questionnaire on cognitive decline in the elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings. Cochrane Database Syst. Rev. 7:CD011333. doi: 10.1002/14651858.CD011333.pub3
Helfand, B. K. I., D’Aquila, M. L., Tabloski, P., Erickson, K., Yue, J., Fong, T. G., et al. (2021). Detecting delirium: a systematic review of identification instruments for non-ICU settings. J. Am. Geriatr. Soc. 69, 547–555. doi: 10.1111/jgs.16879
Herdman, M., Badia, X., and Berra, S. (2001). EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care. Atencion Primaria/Sociedad Española de Medicina de Familia y Comunitaria 28, 425–429. doi: 10.1016/s0212-6567(01)70406-4
Hogue, C. W., Levine, A., Hudson, A., and Lewis, C. (2021). Clinical applications of near-infrared spectroscopy monitoring in cardiovascular surgery. Anesthesiology 134, 784–791. doi: 10.1097/ALN.0000000000003700
Hori, D., Brown, C., Ono, M., Rappold, T., Sieber, F., Gottschalk, A., et al. (2014). Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br. J. Anaesth. 113, 1009–1017. doi: 10.1093/bja/aeu319
Hshieh, T. T., Yang, T., Gartaganis, S. L., Yue, J., and Inouye, S. K. (2018). Hospital elder life program: systematic review and meta-analysis of effectiveness. Am. J. Geriatr. Psychiatr. 26, 1015–1033. doi: 10.1016/j.jagp.2018.06.007
Inouye, S. K., Westendorp, R. G. J., Saczynski, J. S., Naeije, G., and Pepersack, T. (2014). Delirium in elderly people. Lancet 383, 911–922. doi: 10.1016/S0140-6736(13)60688-1
Izquierdo, M., Casas-Herrero, A., Zambom-Ferraresi, F., Martínez-Velilla, N., Alonso-Bouzón, C., Rodríguez-Mañas, L., et al. (2017). Multicomponent physical exercise program VIVIFRAIL. Available at: http://www.vivifrail.com/resources/
Jackson, T. A., Gladman, J. R. F., Harwood, R. H., MacLullich, A. M. J., Sampson, E. L., Sheehan, B., et al. (2017). Challenges and opportunities in understanding dementia and delirium in the acute hospital. PLoS Med. 14, e1002247–e1002249. doi: 10.1371/journal.pmed.1002247
Jeong, E., Park, J., and Lee, J. (2020). Diagnostic test accuracy of the 4AT for delirium detection: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health 17, 1–15. doi: 10.3390/ijerph17207515
Jones, R. N., Cizginer, S., Pavlech, L., Albuquerque, A., Daiello, L. A., Dharmarajan, K., et al. Assessment of instruments for measurement of delirium severity: a systematic review. JAMA Intern. Med. 179, 231–239. doi: 10.1001/jamainternmed.2018.6975
Khan, J. M., Wood, M. D., Lee, K. F. H., Maslove, D., Muscedere, J., English, S. W., et al. (2021). Delirium, cerebral perfusion, and high-frequency vital-sign monitoring in the critically ill the CONFOCAL-2 feasibility study. Ann. Am. Thorac. Soc. 18, 112–121. doi: 10.1513/AnnalsATS.202002-093OC
Koyama, Y., Wada, T., Lohman, B. D., Takamatsu, Y., Matsumoto, J., Fujitani, S., et al. (2013). A new method to detect cerebral blood flow waveform in synchrony with chest compression by near-infrared spectroscopy during CPR. Am. J. Emerg. Med. 31, 1504–1508. doi: 10.1016/j.ajem.2013.07.002
Li, L., Luo, J., Reangsing, C., and Schneider, J. K. (2022). Effects of exercise on depressive symptoms among nursing home residents: a meta-analysis. Aging Ment. Health 26, 1514–1523. doi: 10.1080/13607863.2021.1951658
Luo, X., Qi, Y., Wang, H., Wang, Y., He, T., and Rong, B. (2018). Prefrontal cortex dysfunction during verbal fluency task after Atypicalantipsychotic treatment in schizophrenia: a near-infrared spectroscopy imaging study. Neurosci. Lett. 686, 101–105. doi: 10.1016/j.neulet.2018.09.001
Martínez-Velilla, N., Abizanda, P., Gómez-Pavón, J., Zambom-Ferraresi, F., Sáez, M. L., Asteasu, D., et al. (2022). Effect of an exercise intervention on functional decline in very old patients during acute hospitalizations: results of a multicenter, randomized clinical trial. JAMA Intern. Med. 182, 345–347. doi: 10.1001/jamainternmed.2021.7654
Martínez-Velilla, N., Casas-Herrero, Á., Zambom-Ferraresi, F., De Asteasu, L. S., Mikel, L., Ga/lbete Arkaitz, A., et al. (2019). Effect of exercise intervention on functional decline in very elderly patients during acute hospitalization: a randomized clinical trial. JAMA Intern. Med. 179, 28–36. doi: 10.1001/jamainternmed.2018.4869
Martínez-Velilla, N., Casas-Herrero, A., Zambom-Ferraresi, F., Suárez, N., Alonso-Renedo, J., Contín, K. C., et al. (2015). Functional and cognitive impairment prevention through early physical activity for geriatric hospitalized patients: study protocol for a randomized controlled trial. BMC Geriatr. 15, 1–9. doi: 10.1186/s12877-015-0109-x
Martínez-Velilla, N., Garrués-Irisarri, M., Ibañez-Beroiz, B., Gil-Cabañas, J., Richarte-García, A., Idoate-Saralegui, F., et al. (2016). An exercise program with Patient’s involvement and family support can modify the cognitive and affective trajectory of acutely hospitalized older medical patients: a pilot study. Aging Clin. Exp. Res. 28, 483–490. doi: 10.1007/s40520-015-0434-0
Milej, D., He, L., Abdalmalak, A., Baker, W. B., Anazodo, U. C., Diop, M., et al. (2020). Quantification of cerebral blood flow in adults by contrast-enhanced near-infrared spectroscopy: validation against MRI. J. Cereb. Blood Flow Metab. 40, 1672–1684. doi: 10.1177/0271678X19872564
Moher, D., Schulz, K. F., and Altman, D. G., CONSORT Group (2001). The CONSORT statement: revised recommendations for improving the quality of reports of parallel group Reandomized trials. BMC Med. Res. Methodol. 91, 437–442. doi: 10.1186/1471-2288-1-2
National Institute for Health and Care Excellence (NICE) (2022). “Delirium: prevention, diagnosis and management,” www.nice.org.uk/guidance/cg103 (Accessed March 2019).
Nguyen, T. N., Wen, W., Woldemichael, E., Toronov, V., and Lin, S. (2019). Hyperspectral near-infrared spectroscopy assessment of the brain during Hypoperfusion. J. Biomed. Opt. 24, 1–6. doi: 10.1117/1.jbo.24.3.035007
Noguera, A., Carvajal, A., Alonso-Babarro, A., Chisholm, G., Bruera, E., and Centeno, C. (2014). First Spanish version of the memorial delirium assessment scale: psychometric properties, responsiveness, and factor loadings. J. Pain Symptom Manag. 47, 189–197. doi: 10.1016/j.jpainsymman.2013.02.020
Pfeifer, M. D., Scholkmann, F., and Labruyère, R. (2018). Signal processing in functional near-infrared spectroscopy (FNIRS): methodological differences Lead to different statistical results. Front. Hum. Neurosci. 11:641. doi: 10.3389/fnhum.2017.00641
Rai, M., and Demontis, F. (2022). Muscle-to-brain signaling via Myokines and Myometabolites. Brain Plasticity 8, 43–63. doi: 10.3233/bpl-210133
Reisberg, B., Ferris, S., De Leon, M., and Crook, T. (1982). The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatr. 139, 1136–1139. doi: 10.1176/ajp.139.9.1136
Richardson, S., Murray, J., Davis, D., Stephan, B. C. M., Robinson, L., Brayne, C., et al. (2021). Delirium and delirium severity predict the trajectory of the hierarchical assessment of balance and mobility (HABAM) in hospitalized older people: findings from the DECIDE study. J. Gerontol. 77, 531–535. doi: 10.1093/gerona/glab081
Sakudo, A. (2016). Near-infrared spectroscopy for medical applications: current status and future perspectives. Clin. Chim. Acta 455, 181–188. doi: 10.1016/j.cca.2016.02.009
Schoen, J., Meyerrose, J., Paarmann, H., Heringlake, M., Hueppe, M., and Berger, K. U. (2011). Preoperative regional cerebral oxygen saturation is a predictor of postoperative delirium in on-pump cardiac surgery patients: a prospective observational trial. Crit. Care 15:R218. doi: 10.1186/cc10454
Semrau, J. S., Motamed, M., Ross-White, A., and Gordon Boyd, J. (2021). Cerebral oximetry and preventing neurological complication post-cardiac surgery: a systematic review. Eur. J. Cardiothorac. Surg. 59, 1144–1154. doi: 10.1093/ejcts/ezaa485
Silva, Jason Leonardo, Da, Nounagnon Frutueux, Agbangla, ChristineLe, Page, Wahiba Ghernout, and Andrieu, Bernard. (2022). “Effects of chronic physical exercise or multicomponent exercise programs on the mental health and cognition of older adults living in a nursing home: a systematic review of studies from the past 10 years.” Front. Psychol. 13, 1–9. doi: 10.3389/fpsyg.2022.888851
Susano, M. J., Dias, M., Seixas, F. S., Vide, S., Grasfield, R., Abelha, F. J., et al. (2021). Association among preoperative cognitive performance, regional cerebral oxygen saturation, and postoperative delirium in older Portuguese patients. Anesth. Analg. 132, 846–855. doi: 10.1213/ANE.0000000000005159
Tieges, Z., Maclullich, A. M. J., Anand, A., Brookes, C., Cassarino, M., O’connor, M., et al. (2021). Diagnostic accuracy of the 4AT for delirium detection in older adults: systematic review and meta-analysis. Age Ageing 50, 733–743. doi: 10.1093/ageing/afaa224
Udina, C., Avtzi, S., Durduran, T., Holtzer, R., Rosso, A. L., Castellano-Tejedor, C., et al. (2020). Functional near-infrared spectroscopy to study cerebral hemodynamics in older adults during cognitive and motor tasks: a review. Front. Aging Neurosci. 11, 1–19. doi: 10.3389/fnagi.2019.00367
Venegas-Sanabria, L. C., Cavero-Redondo, I., Martínez-Vizcaino, V., Cano-Gutierrez, C. A., and Álvarez-Bueno, C. (2022). Effect of multicomponent exercise in cognitive impairment: a systematic review and meta-analysis. BMC Geriatr. 22:617. doi: 10.1186/s12877-022-03302-1
Wang, Y. Y., Yue, J. R., Xie, D. M., Carter, P., Li, Q. L., Gartaganis, S. L., et al. (2020). Effect of the tailored, family-involved hospital elder life program on postoperative delirium and function in older adults: a randomized clinical trial. JAMA Intern. Med. 180, 17–25. doi: 10.1001/jamainternmed.2019.4446
Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., Maclullich, A. M. J., et al. (2020). Delirium. Nat. Rev. Dis. Primers 6:90. doi: 10.1038/s41572-020-00223-4
Wood, M. D., Maslove, D. M., Muscedere, J. G., Day, A. G., and Gordon Boyd, J. (2017). Low brain tissue oxygenation contributes to the development of delirium in critically ill patients: a prospective observational study. J. Crit. Care 41, 289–295. doi: 10.1016/j.jcrc.2017.06.009
Keywords: delirium, near-infrared spectroscopy, multicomponent intervention, older adults, physical exercise, geriatric acute care unit
Citation: Lozano-Vicario L, Zambom-Ferraresi F, Zambom-Ferraresi F, de la Casa-Marín A, Ollo-Martínez I, Sáez de Asteasu ML, Cedeño-Veloz BA, Fernández-Irigoyen J, Santamaría E, Romero-Ortuno R, Izquierdo M and Martínez-Velilla N (2022) Effectiveness of a multicomponent exercise training program for the management of delirium in hospitalized older adults using near-infrared spectroscopy as a biomarker of brain perfusion: Study protocol for a randomized controlled trial. Front. Aging Neurosci. 14:1013631. doi: 10.3389/fnagi.2022.1013631
Edited by:
Guoqi Zhu, Anhui University of Chinese Medicine, ChinaReviewed by:
Malissa Mulkey, University of South Carolina, United StatesEduardo Carballeira, University of A Coruña, Spain
Copyright © 2022 Lozano-Vicario, Zambom-Ferraresi, Zambom-Ferraresi, de la Casa-Marín, Ollo-Martínez, Sáez de Asteasu, Cedeño-Veloz, Fernández-Irigoyen, Santamaría, Romero-Ortuno, Izquierdo and Martínez-Velilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lucía Lozano-Vicario, lucia.lozano.vicario@navarra.es